Engineering CAR-T cells

Abstract Chimeric antigen receptor redirected T cells (CAR-T cells) have achieved inspiring outcomes in patients with B cell malignancies, and are now being investigated in other hematologic malignancies and solid tumors. CAR-T cells are generated by the T cells from patients’ or donors’ blood. Afte...

Full description

Bibliographic Details
Main Authors: Cheng Zhang, Jun Liu, Jiang F. Zhong, Xi Zhang
Format: Article
Language:English
Published: BMC 2017-06-01
Series:Biomarker Research
Subjects:
Online Access:http://link.springer.com/article/10.1186/s40364-017-0102-y
_version_ 1818910132522713088
author Cheng Zhang
Jun Liu
Jiang F. Zhong
Xi Zhang
author_facet Cheng Zhang
Jun Liu
Jiang F. Zhong
Xi Zhang
author_sort Cheng Zhang
collection DOAJ
description Abstract Chimeric antigen receptor redirected T cells (CAR-T cells) have achieved inspiring outcomes in patients with B cell malignancies, and are now being investigated in other hematologic malignancies and solid tumors. CAR-T cells are generated by the T cells from patients’ or donors’ blood. After the T cells are expanded and genetically modified, they are reinfused into the patients. However, many challenges still need to be resolved in order for this technology to gain widespread adoption. In this review, we first discuss the structure and evolution of chimeric antigen receptors. We then report on the tools used for production of CAR-T cells. Finally, we address the challenges posed by CAR-T cells.
first_indexed 2024-12-19T22:37:57Z
format Article
id doaj.art-afbda622853c4c01a5b87add9db53a73
institution Directory Open Access Journal
issn 2050-7771
language English
last_indexed 2024-12-19T22:37:57Z
publishDate 2017-06-01
publisher BMC
record_format Article
series Biomarker Research
spelling doaj.art-afbda622853c4c01a5b87add9db53a732022-12-21T20:03:08ZengBMCBiomarker Research2050-77712017-06-01511610.1186/s40364-017-0102-yEngineering CAR-T cellsCheng Zhang0Jun Liu1Jiang F. Zhong2Xi Zhang3Department of Hematology, Xinqiao Hospital, Third Military Medical UniversityDepartment of Hematology, Xinqiao Hospital, Third Military Medical UniversityDivision of Periodontology, Diagnostic Sciences & Dental Hygiene, and Division of Biomedical Sciences, Herman Ostrow School of Dentistry, University of Southern CaliforniaDepartment of Hematology, Xinqiao Hospital, Third Military Medical UniversityAbstract Chimeric antigen receptor redirected T cells (CAR-T cells) have achieved inspiring outcomes in patients with B cell malignancies, and are now being investigated in other hematologic malignancies and solid tumors. CAR-T cells are generated by the T cells from patients’ or donors’ blood. After the T cells are expanded and genetically modified, they are reinfused into the patients. However, many challenges still need to be resolved in order for this technology to gain widespread adoption. In this review, we first discuss the structure and evolution of chimeric antigen receptors. We then report on the tools used for production of CAR-T cells. Finally, we address the challenges posed by CAR-T cells.http://link.springer.com/article/10.1186/s40364-017-0102-yChimeric antigen receptor redirected T cellsCAR-T cellsStructureEvolutionProductionViral vector
spellingShingle Cheng Zhang
Jun Liu
Jiang F. Zhong
Xi Zhang
Engineering CAR-T cells
Biomarker Research
Chimeric antigen receptor redirected T cells
CAR-T cells
Structure
Evolution
Production
Viral vector
title Engineering CAR-T cells
title_full Engineering CAR-T cells
title_fullStr Engineering CAR-T cells
title_full_unstemmed Engineering CAR-T cells
title_short Engineering CAR-T cells
title_sort engineering car t cells
topic Chimeric antigen receptor redirected T cells
CAR-T cells
Structure
Evolution
Production
Viral vector
url http://link.springer.com/article/10.1186/s40364-017-0102-y
work_keys_str_mv AT chengzhang engineeringcartcells
AT junliu engineeringcartcells
AT jiangfzhong engineeringcartcells
AT xizhang engineeringcartcells